Description: Rovista®EZ is a combination of rosuvastatin, an HMG CoA-reductase inhibitor (statin), and ezetimibe, a dietary cholesterol absorption inhibitor, indicated: as an adjunct to diet in patients with primary (heterozygous familial and non-familial) hyperlipidemia to reduce low-density lipoprotein cholesterol (LDL-C)